SEOUL, Dec. 7 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Tuesday its COVID-19 antibody treatment has won emergency approval from Australian authorities. The Therapeutic Goods Administration (TGA) granted provisional approval of Rekirona for the intravenous treatment of mild-to-moderate COVID-19 in adult patients. It is the fifth COVID-19 treatment to receive regulatory approval [...]
SEOUL, Dec. 1 (Korea Bizwire) — The family of a female COVID-19 victim, who died during cohort isolation at a long-term care hospital for senior citizens in Seoul, plans to start a damage suit against the state, their lawyers said Wednesday. The lawsuit will soon be filed with the Seoul Central District Court on behalf [...]
SEOUL, Nov. 30 (Korea Bizwire) — The excess mortality rate of individuals suffering from bipolar disorder in South Korea turned out to be the highest among the Organization for Economic Cooperation and Development (OECD) member states, the health ministry said Monday. Excess mortality rate is a mortality rate of a certain disease in relative terms [...]
SEOUL, Nov. 25 (Korea Bizwire) — South Korean pharmaceutical firm Samsung Biologics Co. said Thursday it has signed a supply agreement with U.S.-based biotech company GreenLight Biosciences. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will manufacture drug substances for GreenLight’s mRNA COVID-19 vaccine candidate. Samsung Biologics will manufacture drug substances of the mRNA [...]
SEOUL, Nov. 23 (Korea Bizwire) — Depression has spread by a factor of five due to the pandemic, a study showed Monday. A research team from Chonnam National University Hospital conducted a survey of 1,492 general participants who had not been infected with COVID-19 and 646 nurses from university hospitals. Among the general participants, 20.9 [...]
SEOUL, Nov. 22 (Korea Bizwire) — The government has decided to raise general awareness of the health risks of smoking once again by setting up an exclusive research institute specializing in the impact of tobacco on public health. The Korea Disease Control and Prevention Agency (KDCA) opened last Wednesday the ‘National Harmful Effects of Cigarette [...]
SEOUL, Nov. 16 (Korea Bizwire) — SK Inc., the holding company of South Korea’s No. 3 conglomerate SK Group, said Tuesday it is in the final talks to invest in a U.S. gene therapy company, in its latest move to expand its foothold in global biopharmaceuticals. SK said it plans to sign a formal deal [...]
SEOUL, Nov. 12 (Korea Bizwire) — The European Union’s drug agency has recommended the approval of a COVID-19 antibody treatment by Celltrion Inc., paving the way for its sales in the region, the South Korean pharmaceutical giant said Friday. The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency recommended the [...]
SEOUL, Nov. 9 (Korea Bizwire) — Korean and American research teams have succeeded in raising the effects of a COVID-19 vaccine by a factor of 100 through the oriental medicine practice of cupping, which is normally used to treat muscle pain. A joint research team led by Prof. Hao Lin from Rutgers University and Dr. [...]
SEOUL, Nov. 8 (Korea Bizwire) — The rate of adverse reaction reports among individuals vaccinated for COVID-19 currently stands at about 45 per 10,000 vaccinations in South Korea, the health authority said. The nation’s vaccination response team, which operates under the umbrella of the Korea Disease Control and Prevention Agency, said that the rate of [...]